Literature DB >> 27995087

Surgery and Hepatocellular Carcinoma.

Nobuhisa Akamatsu1, Umberto Cillo2, Alessandro Cucchetti3, Matteo Donadon4, Antonio Daniele Pinna3, Guido Torzilli4, Norihiro Kokudo1.   

Abstract

The optimal surgical strategy for hepatocellular carcinoma (HCC) is under active debate. Bio-markers of the liver functional reserve as well as volumetric analysis of the future liver remnant are essential for safe liver resection of HCC. The present algorithms applied to surgical strategies for HCC are not ideal because many patients who could potentially undergo safe resection are deemed liver transplant candidates in Western countries, whereas the opposite is the case in Eastern countries. In addition, there is too much focus on expanded criteria for patients with HCC to undergo liver transplantation. The transplantation benefit for patients with HCC should be considered based not only on the individual's benefit, but also on the effect of other patients waiting for LT for other indications.

Entities:  

Keywords:  Hepatocellular carcinoma; Liver resection; Liver transplantation

Year:  2016        PMID: 27995087      PMCID: PMC5159722          DOI: 10.1159/000449344

Source DB:  PubMed          Journal:  Liver Cancer        ISSN: 1664-5553            Impact factor:   11.740


  26 in total

1.  Reply to Letter: "Dissecting EASL/AASLD Recommendations With a More Careful Knife: A Comment on 'Surgical Misinterpretation' of the BCLC Staging System": Real Misinterpretation or Lack of Clarity Within the BCLC?

Authors:  Guido Torzilli; Jacques Belghiti; Norihiro Kokudo; Tadatoshi Takayama; Lorenzo Capussotti; Gennaro Nuzzo; Jean-Nicolas Vauthey; Michael A Choti; Eduardo De Santibanes; Matteo Donadon; Masatoshi Makuuchi
Journal:  Ann Surg       Date:  2015-07       Impact factor: 12.969

2.  Evidence-based Clinical Practice Guidelines for Hepatocellular Carcinoma: The Japan Society of Hepatology 2013 update (3rd JSH-HCC Guidelines).

Authors:  Norihiro Kokudo; Kiyoshi Hasegawa; Masaaki Akahane; Hiroshi Igaki; Namiki Izumi; Takafumi Ichida; Shinji Uemoto; Shuichi Kaneko; Seiji Kawasaki; Yonson Ku; Masatoshi Kudo; Shoji Kubo; Tadatoshi Takayama; Ryosuke Tateishi; Takashi Fukuda; Osamu Matsui; Yutaka Matsuyama; Takamichi Murakami; Shigeki Arii; Masatoshi Okazaki; Masatoshi Makuuchi
Journal:  Hepatol Res       Date:  2015-01       Impact factor: 4.288

3.  Asian consensus workshop report: expert consensus guideline for the management of intermediate and advanced hepatocellular carcinoma in Asia.

Authors:  Kwang-Hyub Han; Masatochi Kudo; Sheng-Long Ye; Jong Young Choi; Roonni Tung-Ping Poon; Jinsil Seong; Joong-Won Park; Takafumi Ichida; Jin Wook Chung; Pierce Chow; Ann-Lii Cheng
Journal:  Oncology       Date:  2011-12-22       Impact factor: 2.935

4.  Can the dropout risk of candidates with hepatocellular carcinoma predict survival after liver transplantation?

Authors:  A Cucchetti; M Cescon; V Bertuzzo; E Bigonzi; G Ercolani; M C Morelli; M Ravaioli; A D Pinna
Journal:  Am J Transplant       Date:  2011-06-10       Impact factor: 8.086

5.  No-mortality liver resection for hepatocellular carcinoma in cirrhotic and noncirrhotic patients: is there a way? A prospective analysis of our approach.

Authors:  G Torzilli; M Makuuchi; K Inoue; T Takayama; Y Sakamoto; Y Sugawara; K Kubota; A Zucchi
Journal:  Arch Surg       Date:  1999-09

Review 6.  Hepatocellular carcinoma.

Authors:  Alejandro Forner; Josep M Llovet; Jordi Bruix
Journal:  Lancet       Date:  2012-02-20       Impact factor: 79.321

7.  A snapshot of the effective indications and results of surgery for hepatocellular carcinoma in tertiary referral centers: is it adherent to the EASL/AASLD recommendations?: an observational study of the HCC East-West study group.

Authors:  Guido Torzilli; Jacques Belghiti; Norihiro Kokudo; Tadatoshi Takayama; Lorenzo Capussotti; Gennaro Nuzzo; Jean-Nicolas Vauthey; Michael A Choti; Eduardo De Santibanes; Matteo Donadon; Emanuela Morenghi; Masatoshi Makuuchi
Journal:  Ann Surg       Date:  2013-05       Impact factor: 12.969

Review 8.  Selection of patients of hepatocellular carcinoma beyond the Milan criteria for liver transplantation.

Authors:  See Ching Chan; Sheung Tat Fan
Journal:  Hepatobiliary Surg Nutr       Date:  2013-04       Impact factor: 7.293

9.  A simple, noninvasively determined index predicting hepatic failure following liver resection for hepatocellular carcinoma.

Authors:  Tsuyoshi Ichikawa; Takahiro Uenishi; Shigekazu Takemura; Kazuki Oba; Masao Ogawa; Shintaro Kodai; Hiroji Shinkawa; Hiromu Tanaka; Takatsugu Yamamoto; Shogo Tanaka; Satoshi Yamamoto; Seikan Hai; Taichi Shuto; Kazuhiro Hirohashi; Shoji Kubo
Journal:  J Hepatobiliary Pancreat Surg       Date:  2008-12-13

10.  Hepatic resection of hepatocellular carcinoma in patients with cirrhosis: Model of End-Stage Liver Disease (MELD) score predicts perioperative mortality.

Authors:  Swee H Teh; John Christein; John Donohue; Florencia Que; Michael Kendrick; Michael Farnell; Stephen Cha; Patrick Kamath; Raymond Kim; David M Nagorney
Journal:  J Gastrointest Surg       Date:  2005-12       Impact factor: 3.267

View more
  20 in total

1.  Diagnostic Value of Different Phenotype Circulating Tumor Cells in Hepatocellular Carcinoma.

Authors:  Yuan Cheng; Lei Luo; Juqiang Zhang; Mantian Zhou; Yujun Tang; Guolin He; Yishi Lu; Zhong Wang; MingXin Pan
Journal:  J Gastrointest Surg       Date:  2019-02-25       Impact factor: 3.452

2.  Nomogram to Assist in Surgical Plan for Hepatocellular Carcinoma: a Prediction Model for Microvascular Invasion.

Authors:  Shengtao Lin; Feng Ye; Weiqi Rong; Ying Song; Fan Wu; Yunhe Liu; Yiling Zheng; Tana Siqin; Kai Zhang; Liming Wang; Jianxiong Wu
Journal:  J Gastrointest Surg       Date:  2019-02-28       Impact factor: 3.452

3.  E2F1-mediated GINS2 transcriptional activation promotes tumor progression through PI3K/AKT/mTOR pathway in hepatocellular carcinoma.

Authors:  Yao Zhang; Xiaopei Hao; Guoyong Han; Yiwei Lu; Zhiqiang Chen; Long Zhang; Jindao Wu; Xuehao Wang
Journal:  Am J Cancer Res       Date:  2022-04-15       Impact factor: 5.942

4.  Preoperative Visceral Adiposity and Muscularity Predict Poor Outcomes after Hepatectomy for Hepatocellular Carcinoma.

Authors:  Yuhei Hamaguchi; Toshimi Kaido; Shinya Okumura; Atsushi Kobayashi; Hisaya Shirai; Siyuan Yao; Shintaro Yagi; Naoko Kamo; Satoru Seo; Kojiro Taura; Hideaki Okajima; Shinji Uemoto
Journal:  Liver Cancer       Date:  2018-06-05       Impact factor: 11.740

5.  Adjuvant therapy after radical surgery for hepatocellular carcinoma: still an unmet need.

Authors:  Yasunori Minami; Masatoshi Kudo
Journal:  Hepatobiliary Surg Nutr       Date:  2019-08       Impact factor: 7.293

6.  Preoperative Low Muscle Mass and Low Muscle Quality Negatively Impact on Pulmonary Function in Patients Undergoing Hepatectomy for Hepatocellular Carcinoma.

Authors:  Hisaya Shirai; Toshimi Kaido; Yuhei Hamaguchi; Atsushi Kobayashi; Shinya Okumura; Siyuan Yao; Shintaro Yagi; Naoko Kamo; Kojiro Taura; Hideaki Okajima; Shinji Uemoto
Journal:  Liver Cancer       Date:  2017-12-08       Impact factor: 11.740

7.  Comparison between liver resection and liver transplantation on outcomes in patients with solitary hepatocellular carcinoma meeting UNOS criteria: a population-based study of the SEER database.

Authors:  Anli Yang; Weiqiang Ju; Xiaopeng Yuan; Ming Han; Xiaoping Wang; Zhiyong Guo; Xiaoli Wei; Dongping Wang; Xiaofeng Zhu; Linwei Wu; Xiaoshun He
Journal:  Oncotarget       Date:  2017-10-30

Review 8.  Small but Heavy Role: MicroRNAs in Hepatocellular Carcinoma Progression.

Authors:  Erbao Chen; Xiaojing Xu; Ruiqi Liu; Tianshu Liu
Journal:  Biomed Res Int       Date:  2018-05-22       Impact factor: 3.411

9.  Limitation of non-transplant treatment and proper timing for liver transplantation in patients with hepatocellular carcinoma considering long-term survival.

Authors:  Aya Nomura; Masatoshi Ishigami; Takashi Honda; Teiji Kuzuya; Yoji Ishizu; Takanori Ito; Hideya Kamei; Yasuharu Onishi; Yasuhiro Ogura; Mitsuhiro Fujishiro
Journal:  Medicine (Baltimore)       Date:  2020-07-10       Impact factor: 1.817

10.  Adjuvant pegylated interferon therapy improves the survival outcomes in patients with hepatitis-related hepatocellular carcinoma after curative treatment: A meta-analysis.

Authors:  Jiansong Wu; Zhiwei Yin; Liuxia Cao; Xiaodan Xu; Tao Yan; Changting Liu; Diangeng Li
Journal:  Medicine (Baltimore)       Date:  2018-07       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.